北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学临床肿瘤学院  > 期刊论文
学科主题: 临床医学
题名:
A 3-DAY ORAL APREPITANT REGIMEN PROVIDES SUPERIOR PREVENTION OF CINV OVER STANDARD THERAPY IN CHINESE PATIENTS RECEIVING HIGH-DOSE CISPLATIN
作者: Zhang, Li1; Cheng, Ying2; Zhang, Hong-Yu3; Zhou, Caicun4; Han, Baohui5; Zhang, Yiping6; Huang, Cheng7; Chang, Jianhua8; Song, Xiang Q.9; Liang, Jun10; Liang, Houjie11; Bai, Chunxue12; Yu, Shiying13; Chen, Jia14; Wang, Jie15; Pan, Hongming16; Carides, Alexandra17; Chitkara, Denesh17
关键词: high-dose cisplatin ; Aprepitant ; CINV
刊名: JOURNAL OF THORACIC ONCOLOGY
发表日期: 2011-06-01
卷: suppl.2, 期:6, 页:S458-S459
收录类别: SCI
文章类型: Meeting Abstract
WOS标题词: Science & Technology
类目[WOS]: Oncology ; Respiratory System
研究领域[WOS]: Oncology ; Respiratory System
语种: 英语
WOS记录号: WOS:000208855802185
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/52500
Appears in Collections:北京大学临床肿瘤学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Canc Hosp Fujian, Dept Med, Fuzhou, Fujian, Peoples R China
2.Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
3.Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
4.Tongji Hosp, Wuhan, Hubei, Peoples R China
5.Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
6.Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China
7.Merck & Co Inc, Whitehouse Stn, NJ USA
8.Jilin Prov Canc Hosp, Changchun, Peoples R China
9.Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
10.Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
11.Sun Yat Sen Univ, Hosp Affiliated 5, Guangzhou, Guangdong, Peoples R China
12.Tongji Univ, Affiliated Shanghai Pulm Hosp, Shanghai, Peoples R China
13.Shanghai Jiao Tong Univ, Affiliated Shanghai Chest Hosp, Shanghai 200030, Peoples R China
14.Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Peoples R China
15.Qingdao Univ, Affiliated Hosp, Qingdao, Shandong, Peoples R China
16.Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China
17.Peking Univ, Sch Oncol, Beijing Canc Hosp, Beijing, Peoples R China

Recommended Citation:
Zhang, Li,Cheng, Ying,Zhang, Hong-Yu,et al. A 3-DAY ORAL APREPITANT REGIMEN PROVIDES SUPERIOR PREVENTION OF CINV OVER STANDARD THERAPY IN CHINESE PATIENTS RECEIVING HIGH-DOSE CISPLATIN[J]. JOURNAL OF THORACIC ONCOLOGY,2011,suppl.2(6):S458-S459.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhang, Li]'s Articles
[Cheng, Ying]'s Articles
[Zhang, Hong-Yu]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhang, Li]‘s Articles
[Cheng, Ying]‘s Articles
[Zhang, Hong-Yu]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace